AlphaYouEG
Insider selling
Erick Gamelin sold $804 of Acrivon Therapeutics, Inc. (ACRV) stock
Erick Gamelin, Chief Development Officer of Acrivon Therapeutics, Inc. (ACRV), sold 400 shares of ACRV stock worth $804, per an SEC Form 4 filed Aug 20, 2026.
It was an open-market sale.
The trade happened on Aug 18, 2026, 2 days before it was made public.
ACRV has moved +4.9% since the trade date, from $2.05 to $2.15 (Sep 22, 2026 close).
- Traded
- Aug 18, 2026
- Disclosed
- Aug 20, 2026
- Filing delay
- 2 days
- Price since
- +4.9%
- Role
- Chief Development Officer
- Source
- SEC Form 4
More ACRV insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.